Literature DB >> 2836606

Translational efficiency of poliovirus mRNA: mapping inhibitory cis-acting elements within the 5' noncoding region.

J Pelletier1, G Kaplan, V R Racaniello, N Sonenberg.   

Abstract

Poliovirus mRNA contains a long 5' noncoding region of about 750 nucleotides (the exact number varies among the three virus serotypes), which contains several AUG codons upstream of the major initiator AUG. Unlike most eucaryotic mRNAs, poliovirus does not contain a m7GpppX (where X is any nucleotide) cap structure at its 5' end and is translated by a cap-independent mechanism. To study the manner by which poliovirus mRNA is expressed, we examined the translational efficiencies of a series of deletion mutants within the 5' noncoding region of the mRNA. In this paper we report striking translation system-specific differences in the ability of the altered mRNAs to be translated. The results suggest the existence of an inhibitory cis-acting element(s) within the 5' noncoding region of poliovirus (between nucleotides 70 and 381) which restricts mRNA translation in reticulocyte lysate, wheat germ extract, and Xenopus oocytes, but not in HeLa cell extracts. In addition, we show that HeLa cell extracts contain a trans-acting factor(s) that overcomes this restriction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836606      PMCID: PMC253356          DOI: 10.1128/JVI.62.7.2219-2227.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Receptor affinities as major determinants of enterovirus tissue tropisms in humans.

Authors:  J J HOLLAND
Journal:  Virology       Date:  1961-11       Impact factor: 3.616

2.  Covalent linkage of a protein to a defined nucleotide sequence at the 5'-terminus of virion and replicative intermediate RNAs of poliovirus.

Authors:  J B Flanegan; R F Petterson; V Ambros; N J Hewlett; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

3.  Inhibition of HeLa cell messenger RNA translation by 7-methylguanosine 5'-monophosphate.

Authors:  L A Weber; E R Feman; E D Hickey; M C Williams; C Baglioni
Journal:  J Biol Chem       Date:  1976-09-25       Impact factor: 5.157

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  5'-Terminal structure and mRNA stability.

Authors:  Y Furuichi; A LaFiandra; A J Shatkin
Journal:  Nature       Date:  1977-03-17       Impact factor: 49.962

6.  Functional identity of a mouse ascites and a rabbit reticulocyte initiation factor required for natural mRNA translation.

Authors:  G E Blair; H H Dahl; E Truelsen; J C Lelong
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

7.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

8.  5'-terminal structure of poliovirus polyribosomal RNA is pUp.

Authors:  M J Hewlett; J K Rose; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

9.  The 5' end of poliovirus mRNA is not capped with m7G(5')ppp(5')Np.

Authors:  A Nomoto; Y F Lee; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

10.  A protein covalently linked to poliovirus genome RNA.

Authors:  Y F Lee; A Nomoto; B M Detjen; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

View more
  33 in total

1.  Specific interactions of HeLa cell proteins with proposed translation domains of the poliovirus 5' noncoding region.

Authors:  J R Gebhard; E Ehrenfeld
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

2.  Intracellular modifications induced by poliovirus reduce the requirement for structural motifs in the 5' noncoding region of the genome involved in internal initiation of protein synthesis.

Authors:  N Percy; G J Belsham; J K Brangwyn; M Sullivan; D M Stone; J W Almond
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

3.  Conservation of RNA-protein interactions among picornaviruses.

Authors:  S L Dildine; B L Semler
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

4.  Translation of poliovirus RNA: role of an essential cis-acting oligopyrimidine element within the 5' nontranslated region and involvement of a cellular 57-kilodalton protein.

Authors:  T V Pestova; C U Hellen; E Wimmer
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  A complex RNA sequence determines the internal initiation of encephalomyocarditis virus RNA translation.

Authors:  A G Evstafieva; T Y Ugarova; B K Chernov; I N Shatsky
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

6.  Roles of LEF-4 and PTP/BVP RNA triphosphatases in processing of baculovirus late mRNAs.

Authors:  Yi Li; Linda A Guarino
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

7.  Conservation of the secondary structure elements of the 5'-untranslated region of cardio- and aphthovirus RNAs.

Authors:  E V Pilipenko; V M Blinov; B K Chernov; T M Dmitrieva; V I Agol
Journal:  Nucleic Acids Res       Date:  1989-07-25       Impact factor: 16.971

8.  The 5' noncoding region of the human leukemia-associated oncogene BCR/ABL is a potent inhibitor of in vitro translation.

Authors:  A J Muller; O N Witte
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

9.  Low efficiency of the 5' nontranslated region of hepatitis A virus RNA in directing cap-independent translation in permissive monkey kidney cells.

Authors:  L E Whetter; S P Day; O Elroy-Stein; E A Brown; S M Lemon
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  Effects of antisense oligodeoxynucleotide hybridization on in vitro translation of potato virus Y RNA.

Authors:  C Levis; M Tronchet; M Meyer; J Albouy; S Astier-Manifacier
Journal:  Virus Genes       Date:  1992-01       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.